EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Quantitative Hepatobiliary MRI for Early Prognostic Assessment After Liver Transplantation: Survival Prediction Using the Contrast Enhancement Index

Luigi Asmundo, Leonardo Mariani, Chiara Mazzarelli, Vittoria Poggi, Valentina Forte, Francesco Rizzetto, Caterina Beatrice Monti, Leonardo Centonze, Domenico Albano, Stefano Di Sandro, Angelo Vanzulli

British Journal of Radiology · 2026-11-05

DOI: 10.1093/bjr/tqag268 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives To evaluate the feasibility and prognostic value of the contrast enhancement index (CEI) derived from gadobenate dimeglumine (Gd-BOPTA)-enhanced hepatobiliary-phase (HBP) magnetic resonance imaging (MRI) for early assessment of liver graft function after liver transplantation (LT). Methods This retrospective study included LT recipients undergoing Gd-BOPTA-enhanced MRI within 6 months after transplantation. CEI was calculated using liver-to-psoas signal intensity ratios on pre-contrast and HBP images acquired 90–120 minutes after contrast administration. ROC, Kaplan–Meier, and age-adjusted Cox regression analyses evaluated associations with mortality. Results Seventy patients (median age, 62 years; interquartile range [IQR], 48–74) were included. CEI was quantifiable in all cases (median, 1.27; IQR, 1.09–1.37). Non-survivors had significantly lower CEI values than survivors (median, 1.17 vs 1.31; p = 0.03; Cliff’s δ = −0.28). ROC analysis showed moderate discrimination for mortality (AUC, 0.667; 95% CI, 0.529–0.793), with an optimal cutoff of 1.301 (sensitivity, 88%; specificity, 51.2%). Patients with CEI <1.301 had significantly lower overall survival (log-rank p = 0.028). After adjustment for recipient age, CEI remained associated with mortality (HR per 0.1-unit increase, 0.79; 95% CI, 0.64–0.98; p = 0.035). Conclusion Quantitative CEI measurement on Gd-BOPTA HBP MRI is feasible after LT, and lower CEI values. Advances in knowledge This study links quantitative Gd-BOPTA-enhanced HBP MRI with overall survival after LT, supporting CEI as a potential non-invasive imaging biomarker for postoperative risk stratification.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →